Biphasic positive effect of formononetin on metabolic activity of human normal and osteoarthritic subchondral osteoblasts

International Immunopharmacology

Volumn 10, Issue 4, 2010, Pages 500-507

  Huh, Jeong Eun ^a   Seo, Dong Min ^a   Baek, Yong Hyeon ^b   Choi, Do Young ^a   Park, Dong Suk ^b   Lee, Jae Dong ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Formononetin; Inflammatory mediators; Osteoarthritis; Osteogenic; Subchondral osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; FORMONONETIN; INTERLEUKIN 6; OSTEOCALCIN; PHYTOESTROGEN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ASTRAGALUS MEMBRANACEUS; BONE METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOARTHRITIS; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ALKALINE PHOSPHATASE; ASTRAGALUS MEMBRANACEUS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; ISOFLAVONES; OSTEOARTHRITIS; OSTEOBLASTS; OSTEOCALCIN; PHYTOESTROGENS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949652721     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.01.012     Document Type: Article

References (37)

1. Martel-Pelletier J., Lajeunesse D., and Pelletier J.P. Etiopathogenesis of osteoarthritis. In: Koopman W.J., and Moreland L.W. (Eds). Arthritis and allied conditions: a textbook of rheumatology (2005), Williams Wilkins, Baltimore 2199-2226
2. Lajeunesse D., Massicotte F., Pelletier J.P., and Martel-Pelletier J. Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander. Mod Rheumatol 13 (2003) 7-14
3. Pelletier J.P., Martel-Pelletier J., and Howell D.S. Etiopathogenesis of osteoarthritis. In: Koopman W.J. (Ed). Arthritis & allied conditions. A textbook of rheumatology (14th ed.) (2001), Williams & Wilkins, Baltimore 2195-2245
4. Hilal G., Martel-Pelletier J., Pelletier J.P., Ranger P., and Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 41 (1998) 891-899
5. Dequeker J., Mohan R., Finkelman R.D., Aerssens J., and Baylink D.J. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 36 (1993) 1702-1708
6. Mansell J.P., Tarlton J.F., and Bailey A.J. Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip. Br J Rheumatol 36 (1997) 16-19
7. Mansell J.P., and Bailey A.J. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest 101 (1998) 1596-1603
8. Hilal G., Martel-Pelletier J., Pelletier J.P., Duval N., and Lajeunesse D. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts. Arthritis Rheum 42 (1999) 2112-2122
9. Radin E.L., and Rose R.M. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res 213 (1986) 34-40
10. Hilal G., Massicotte F., Martel-Pelletier J., Fernandes J.C., Pelletier J.P., and Lajeunesse D. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. J Bone Miner Res 16 (2001) 713-721
11. Chen X.J., Meng D., Feng L., Bian Y.Y., Li P., Yang D., et al. Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats. Am J Chin Med 34 (2006) 1015-1025
12. Jarred R.A., Keikha M., Dowling C., McPherson S.J., Clare A.M., Husband A.J., et al. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev 11 (2002) 1689-1696
13. Ososki A.L., and Kennelly E.J. Phytoestrogens: a review of the present state of research. Phytother Res 17 (2003) 845-869
14. Atkinson C., Compston J.E., Day N.E., Dowsett M., and Bingham S.A. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79 (2004) 326-333
15. Nestel P., Fujii A., and Zhang L. An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. Atherosclerosis 192 (2007) 184-189
16. Kurzer M.S., and Xu X. Dietary phytoestrogens. Annu Rev Nutr 7 (1997) 353-381
17. Branca F., and Lorenzetti S. Health effects of phytoestrogens. Forum Nutr 57 (2005) 100-111
18. Cotter A., and Cashman K.D. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 61 (2003) 346-351
19. Choi S.I., Heo T.R., Min B.H., Cui J.H., Choi B.H., and Park S.R. Alleviation of osteoarthritis by calycosin-7-O-beta-D-glucopyranoside (CG) isolated from Astragali radix (AR) in rabbit osteoarthritis (OA) model. Osteoarthritis Cartilage 15 (2007) 1086-1092
20. Kim C., Ha H., Lee J.H., Kim J.S., Song K., and Park S.W. Herbal extract prevents bone loss in ovariectomized rats. Arch Pharm Res 26 (2003) 917-924
21. Wu F., and Chen X. A review of pharmacological study on Astragalus membranaceus (Fisch.) Bge. Zhong Yao Cai 27 (2004) 232-234
22. Massicotte F., Lajeunesse D., Benderdour M., Pelletier J.P., Hilal G., Duval N., et al. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthr Cartil 10 (2002) 491-500
23. Hilal G., Martel-Pelletier J., Pelletier J.P., Ranger P., and Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 41 (1998) 891-899
24. Cantatore F.P., Corrado A., Grano M., Quarta L., Colucci S., and Melillo N. Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation. Clin Rheumatol 23 (2004) 490-495
25. Mansell J.P., and Bailey A.J. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest 101 (1998) 1596-1603
26. Dequeker J., Mohan S., Finkelman R.D., Aerssens J., and Baylink D.J. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 36 (1993) 1702-1708
27. Bailey A.J., Sims T.J., and Knott L. Phenotypic expression of osteoblast collagen in osteoarthritic bone: production of type I homotrimer. Int J Biochem Cell Biol 34 (2002) 176-182
28. Sanchez C., Deberg M.A., Bellahcène A., Castronovo V., Msika P., Delcour J.P., et al. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum 58 (2008) 442-455
29. Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., Destefano J., et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50 (2004) 1193-1206
30. Sanchez C., Deberg M.A., Burton S., Devel P., Reginster J.Y., and Henrotin Y. Differential regulation of chondrocyte metabolism by oncostatin M and interleukin-6. Osteoarthritis Cartilage 10 (2004) 801-810
31. Bendre M.S., Montague D.C., Peery T., Akel N.S., Gaddy D., and Suva L.J. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 33 (2003) 28-37
32. 2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 10 (2002) 491-500
33. Chang H., Jin T.Y., Jin W.F., Gu S.Z., and Zhou Y.F. Modulation of isoflavones on bone-nodule formation in rat calvaria osteoblasts in vitro. Biomed Environ Sci 16 (2003) 83-89
34. Olson E.J., Lindgren B.R., and Carlson C.S. Effects of long-term estrogen replacement therapy on bone turnover in periarticular tibial osteophytes in surgically postmenopausal cynomolgus monkeys. Bone 42 (2008) 907-913
35. Ham K.D., and Carlson C.S. Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. J Bone Miner Res 19 (2004) 823-829
36. Claassen H., Briese V., Manapov F., Nebe B., Schünke M., and Kurz B. The phytoestrogens daidzein and genistein enhance the insulin-stimulated sulfate uptake in articular chondrocytes. Cell Tissue Res 333 (2008) 71-79
37. Sanchez C., Deberg M.A., Piccardi N., Msika P., Reginster J.Y.L., and Henrotin Y.E. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1β and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 13 (2005) 979-987